TKNO
Alpha Teknova, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.21
−10.94%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.10x
- Price / sales
- 10.17x
- Price / cash flow
- -73.22x
Enterprise value
- Enterprise value
- $454.5M
- EV / sales
- 10.40x
- EV / EBITDA
- -48.04x
- EV / EBIT
- -28.74x
- Market cap
- $444.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026